Готові списки джерел за темами / Cerebrovascular disease

Добірка наукової літератури з теми "Cerebrovascular disease"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 3 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cerebrovascular disease".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Статті в журналах з теми "Cerebrovascular disease":

1

Gorelick, Philip B. "Cerebrovascular Disease." Nursing Clinics of North America 21, no. 2 (June 1986): 275–88. http://dx.doi.org/10.1016/s0029-6465(22)00416-9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Wolf, P. A., and J. C. Grotta. "Cerebrovascular Disease." Circulation 102, Supplement 4 (November 14, 2000): IV—75—IV—80. http://dx.doi.org/10.1161/01.cir.102.suppl_4.iv-75.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Frost, Elizabeth A. M. "Cerebrovascular disease." Current Opinion in Anaesthesiology 4, no. 5 (October 1991): 639–44. http://dx.doi.org/10.1097/00001503-199110000-00002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Herrick, Ian A. "Cerebrovascular disease." Current Opinion in Anaesthesiology 16, no. 3 (June 2003): 337–42. http://dx.doi.org/10.1097/00001503-200306000-00016.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Caprio, Fan Z., and Farzaneh A. Sorond. "Cerebrovascular Disease." Medical Clinics of North America 103, no. 2 (March 2019): 295–308. http://dx.doi.org/10.1016/j.mcna.2018.10.001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Holloway, R. G. "Cerebrovascular Disease." Neurology 49, no. 4 (October 1, 1997): 1192. http://dx.doi.org/10.1212/wnl.49.4.1192.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sacco, Ralph L., and Tatjana Rundek. "Cerebrovascular disease." Current Opinion in Neurology 25, no. 1 (February 2012): 1–4. http://dx.doi.org/10.1097/wco.0b013e32834f89b1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Caplan, Louis R., D. Eric Searls, and Fong Kwong Sonny Hon. "Cerebrovascular Disease." Medical Clinics of North America 93, no. 2 (March 2009): 353–69. http://dx.doi.org/10.1016/j.mcna.2008.09.004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Bowsher, David, G. Vantrappen, David Mabey, Tom Treasure, KentL Woods, WilliamP Arend, and David Bowsher. "CEREBROVASCULAR DISEASE." Lancet 341, no. 8838 (January 1993): 156. http://dx.doi.org/10.1016/0140-6736(93)90015-9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Bonita, Ruth, and Robert Beaglehole. "CEREBROVASCULAR DISEASE." Lancet 341, no. 8859 (June 1993): 1510–11. http://dx.doi.org/10.1016/0140-6736(93)90640-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "Cerebrovascular disease" для конкретних типів джерел:
Статті в журналах Дисертації Книги

Дисертації з теми "Cerebrovascular disease":

1

Holt, Jim, and Gregg Mitchell. "Cerebrovascular Disease KSA." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/etsu-works/6458.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Murphy, Jeremy James. "Clinical trials in cerebrovascular disease." Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293328.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Man, Lai-mei. "An exploratory study for the health seeking pattern of stroke survivors on alternative medicine." Hong Kong : University of Hong Kong, 1998. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20133236.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Williams, David James. "Near infrared spectroscopy in cerebrovascular disease." Thesis, University of Bath, 2002. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426180.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Hoffmann, Tammy Coral. "Development and evaluation of a computer-generated individualised written education package for patients following stroke and their carers /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18924.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Wan, Wai-kuen Christina. "An exploratory design of an empowerment group for the stroke survivors." Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19469937.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Li, Sijian. "Evaluating the effectiveness of a stroke education programme in Wuhan City of China /." Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20793224.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Fung, Mei-ling. "Stroke rehabilitation : predicting LOS and discharge placement /." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25101298.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Gibbs, Richard Geoffrey James. "The aetiology and epidemiology of cerebrovascular disease." Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405270.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Chan, Chi-wing Martin. "Is bilateral isokinematic training (BIT) more effective than unilateral limb training in improving the hemiplegic upper-limb function /." View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30469697.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Cerebrovascular disease":

1

Vladimir, Hachinski, ed. Cerebrovascular disease. London: Baillière Tindall, 1995.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Hunt, Batjer H., ed. Cerebrovascular disease. Philadelphia: Lippincott-Raven, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

1924-, Kameyama Masakuni, Tomonaga Masanori, and Aiba Tadashi, eds. Cerebrovascular disease. Tokyo: Igaku-Shoin, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

L, Babikian Viken, Wechsler Lawrence R, and Higashida Randall T, eds. Imaging cerebrovascular disease. Philadelphia: Butterworth-Heinemann, 2003.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

S, Moore Wesley, ed. Surgery for cerebrovascular disease. 2nd ed. Philadelphia: W.B. Saunders, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

B, Gorelick Philip, ed. Atlas of cerebrovascular disease. Philadelphia: Current Medicine, 1995.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

B, Gorelick Philip, and Sloan Michael A, eds. Atlas of cerebrovascular disease. 2nd ed. Philadelphia: Current Medicine, 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

J, Alberts Mark, ed. Genetics of cerebrovascular disease. Armonk, NY: Futura Pub. Co., 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

S, Moore Wesley, ed. Surgery for cerebrovascular disease. New York: Churchill Livingstone, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

M, Sundt Thoralf, and Meyer Fredric B, eds. Sundt's Occlusive cerebrovascular disease. 2nd ed. Philadelphia, PA: W.B. Saunders, 1994.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Cerebrovascular disease":

1

Wagle, Kamal C. "Cerebrovascular Disease." In Family Medicine, 837–49. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_72.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gerhard-Herman, Marie, and Aaron Aday. "Cerebrovascular Disease." In Manual of Vascular Medicine, 63–72. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44715-1_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Roth, Elliot J. "Cerebrovascular Disease." In Encyclopedia of Clinical Neuropsychology, 740–41. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2167.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Patel, Sheela T., and K. Craig Kent. "Cerebrovascular Disease." In Surgery, 1005–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-57282-1_45.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Roth, Elliot J. "Cerebrovascular Disease." In Encyclopedia of Clinical Neuropsychology, 536. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2167.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

McCabe, Melvina. "Cerebrovascular Disease." In Family Medicine, 557–64. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_65.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Orsini, Donna L., Wilfred G. van Gorp, and Kyle B. Boone. "Cerebrovascular Disease." In The Neuropsychology Casebook, 40–68. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3836-2_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Fowler, T. J., and R. W. May. "Cerebrovascular Disease." In Neurology, 115–24. Dordrecht: Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-010-9544-0_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Roth, Elliot J. "Cerebrovascular Disease." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2167-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

McCabe, Melvina L. "Cerebrovascular Disease." In Family Medicine, 494–501. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_65.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Cerebrovascular disease":

1

Axelerad, Docu Any, Daniel Docu-Axelerad, and Valentin Negrea. "Smoking and the Cerebrovascular Disease." In DIALOGO-CONF 2018 OVERPOPULATION AND RELIGION's INVOLMENT (ORI). EDIS - Publishing Institution of the University of Zilina, Slovak Republic, 2018. http://dx.doi.org/10.18638/dialogo.2018.4.2.9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Estévez, M., A. Argibay, L. Rodriguez, M. Freire, B. Gimena, J. Fernández-Martín, and A. Rivera. "FRI0289 Cerebrovascular disease in the antiphospholipid syndrome." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4509.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gramasco, Hendrick Henrique Fernandes, Mateus Felipe dos Santos, Yasmim Nadime José Frigo, Guilherme Drumond Jardini Anastácio, Stella de Angelis Trivellato, Daniel Fabiano Barbosa dos Santos, Ana Cláudia Pires Carvalho, et al. "Diverse clinical presentations of Moyamoya disease: a case series." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.530.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Context: Moyamoya disease or chronic occlusive cerebrovascular disease is characterized by proximal occlusion of the internal carotid artery and its branches bilaterally, generating an angiographic “smoke” pattern (moyamoya, from Japanese “something hazy”) and by diverse ischemic manifestations. Case report: The sample consists of three female patients, aged between 13 and 46 years, followed in our service due to the diagnosis of Moyamoya Disease. Among the clinical manifestations presented, ischemic cerebrovascular events with neurological deficit predominated, and one of the patients presented two episodes compatible with stroke and one episode compatible with transient ischemic accident. The youngest patient presented with a choreic picture initially interpreted as Sydenham’s chorea. Although the gold standard for the diagnosis of chronic occlusive cerebrovascular disease is cerebral arterial angiography, it was possible to observe a pattern compatible with the disease in other modalities of examination, such as cerebral arterial angiotomography and cerebral arterial angioresonance. From the therapeutic point of view, one of the patients underwent surgical intervention (encephaloduromyosinangiosis), with improvement of symptoms after treatment. Conclusions: In this paper, we emphasize the importance of complementary imaging tests in the evaluation of patients with cerebrovascular syndromes and the diversity of clinical presentation of Moyamoya disease.
4

Martins, Karine Felipe, Flávia Pascoal Teles, Amanda Fernandes de Sousa Oliveira Balestra, and Isadora Rosa Maia. "Cerebrovascular diseases: the importance of recognizing them." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.188.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: Until the 70s, cerebrovascular diseases (CVDs) were neglected to the lack of resources. However, due to the advancement of technology, several imaging tests have appeared, such as magnetic resonance and computed tomography, which facilitated the diagnosis and the understanding of the pathophysiology of each disease. Objectives: The objective of this work is to identify the main CVDs signs and symptoms. Methods: An integrative literature review was carried out based on selected articles from Google Scholar, PubMed and SciELO, using the terms headache, cerebrovascular disease, neurology. Results: CVDs are characterized by causing damage to brain vessels, due to changes in blood flow momentarily or permanently in an area of the brain, allowing them to be classified as ischemic or hemorrhagic. In ischemic there is a blockage of blood flow and, consequently, of oxygen to areas of the brain, in hemorrhagic rupture of a vessel occurs and, with this, blood leakage. Therefore, it is necessary to recognize the signs and symptoms early, in order to prevent loss of neurological function, movements on one side of the body and the presence or absence of headaches in both patients, with ischemic CVD and hemorrhagic CVD prevent rapid loss of consciousness accompanied by severe headache. Such signs and symptoms associated with the patient’s family history and lifestyle can help in the diagnosis of this disease. Conclusion: Therefore, it is important to recognize the signs and symptoms of CVDs, in order to determine the treatment and advise the patient, which will guarantee a better prognosis.
5

Qiang Sun, Qiang, Jiang Jiang Yuan, and Lei Lei Zeng. "Interventional Therapy of Cerebrovascular Disease Mechanical Embolic Materials." In 2015 International Conference on Mechanical Science and Engineering. Paris, France: Atlantis Press, 2016. http://dx.doi.org/10.2991/mse-15.2016.8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Oliveira, Francisco Gabriel Cabral, Juliana Paiva Ribeiro Moura, Matheus Henrique Oliveira, and Mylena Teles de Jesus. "The relation between COVID-19 and cerebrovascular diseases." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.740.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introduction: Covid-19 is characterized by respiratory syndrome and has symptoms that affect the central nervous system such as headache, anosmia, hypercoagulability, etc. In this sense, it is known that the virus shows tropism by the receptors of the angiotensin-converting enzyme 2 (ACE2), becoming a gateway to the neurological system, which can cause complications. Is to relate the infection by COVID-19 and the increase in cerebrovascular diseases. Methods: A literature review was carried out using search for scientific articles in PubMed, in April / 2021, with a filter in the last 5 years, using the descriptors “Covid”, “Cerebrovascular Diseases” and “Man” associated with the Boolean operator AND. Results: 53 articles were found, of which 19 were selected for research. There is a higher frequency of neurological symptoms in patients with COVID-19 than in patients without the disease. The effect of binding the virus to ACE2 receptors is to activate a cascade of cytokines, which tends to lead to serious complications. For this reason, severe coagulopathies can be caused, increasing products of the degradation of C-reactive protein, D Dimer, fibrinogen and thrombocytopenia. The increase in cerebrovascular events also occurs because the antithrombotic, neuroprotective, antihypertensive effects, among others, of the alternative renin-angiotensin system in the brain are interrupted due to COVID-19. Conclusion: It was seen that cerebrovascular events are related to the course of COVID-19, in which patients may develop several serious complications, such as encephalitis, strokes and vascular thrombosis. Thus, the pathophysiology of this disease is related to an inflammatory process.
7

Rahman, G. M. Mahmudur, H. Okazawa, Md Sherajul Islam, Md Shahjahan, and S. S. Zakir. "Probing the neuronal status for cerebrovascular disease using EEG." In 2017 International Conference on Electrical, Computer and Communication Engineering (ECCE). IEEE, 2017. http://dx.doi.org/10.1109/ecace.2017.7912926.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

SOSSI, VESNA. "PET for cerebrovascular diseases: status and limitation." In Frontiers in Imaging Science: High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart). Trieste, Italy: Sissa Medialab, 2008. http://dx.doi.org/10.22323/1.039.0017.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Mesquita, Rodrigo da Rosa, Tatiana Farias de Oliveira, Gibson Barros de Almeida Santana, Antônio Leopoldo do Nascimento Gama Albuquerque, Amanda Karine Barros Ferreira Rodrigues, and Carlos Dornels Freire de Souza. "Epidemiological profile and temporal trend of mortality from cerebrovascular diseases in Northeast of Brazil, 1996-2016." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.600.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: Cerebrovascular diseases represent the second leading cause of mortality in the world and Brazil occupies the leadership in the ranking of mortality in South America. Objectives: This study sought to analyze the sociodemographic profile and the time trend of the mortality rate from cerebrovascular disease in the Northeast of Brazil, 1996-2016. Methods: This is an ecological study of time series involving deaths from cerebrovascular diseases in the Northeastern of Brazil, 1996-2016. Sociodemographic variables (age, schooling, marital status, skin color, ICD category and federation units) were included and calculated crude and standardized mortality rates, according to gender and age group. A joinpoint regression model was applied for the temporal analysis, with a level of significance of 5%. Results: There were 490.433 deaths from cerebrovascular diseases in the Northeast of Brazil, 1996-2016. Of these deaths, 50,03% (n = 245.354) were women, 79,72% (n = 390.957) elderly, 46,66% (n = 228.851) brown, 51,81% (n = 332.439) illiterate and 37,93% (n = 186.014) were married. Of the causes of death, 56,63% (n = 277.741) resulted from stroke, not specified as hemorrhagic or ischemic (I64). In the Northeast, there was a predominance of the elderly population, with growth of 1.2% (p < 0.001). Conclusions: Standardized mortality increased in four states, being higher in Maranhão and Piauí, with a predominance of females and age equal to or above 60 years.
10

Mou, Xiao, Xingce Wang, Zhongke Wu, Xuesong Wang, and Mingquan Zhou. "An automatic eHealth platform for cardiovascular and cerebrovascular disease detection." In 2015 International Symposium on Bioelectronics and Bioinformatics (ISBB). IEEE, 2015. http://dx.doi.org/10.1109/isbb.2015.7344924.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Cerebrovascular disease":

1

Chen, Qian, and Qinhao Wang. The neuroprotective effect of edaravone dexborneol in cerebrovascular disease: a comprehensive systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0069.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Roldán-González, Elizabeth, Carolina Robledo-Castro, Piedad Rocío Lerma-Castaño, and María Luisa Hurtado-Otero. Validity and reliability of the Wolf Motor Function Test -WMFT in patients with Cerebrovascular disease: Scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0044.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: This scoping review aimed to compile the studies that have examined the validity and reliability of the different versions of the Wolf Motor Function Test - WMFT in patients with Cerebrovascular disease. Background: Numerous investigations in rehabilitation have used the WMFT as an instrument for the primary measurement of the results; however, to date, there are no known reviews that have compiled the reliability and validity of the wolf test in its different versions, which is considered of vital importance and constitutes critical information for decision making in the process of evaluation and follow-up of patients with stroke in clinical, academic and research environments.
3

Hu, XinYi, JingXuan Hao, and HangYue Wang. Improvement of Environmental enrichment on Cognitive Functions in Patients and animals : A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0014.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: To study the relationship between environmental enrichment and cognitive function through a meta-analysis of the literature, analyze its effects on the improvement of cognitive function in patients and animals, and evaluate the effects of different environmental enrichment measures on cognitive function improvement. Condition being studied: Cognitive decline refers to an individual's memory, language, reasoning and other aspects of cognitive function showing obvious, measurable decline or abnormal. The causes of cognitive decline are various, including neurodegeneration, cerebrovascular disease, infection, trauma, and depression. Alzheimer's disease and stroke are the most common.
4

LI, Peng, and Junjun Liu. Effect of statin therapy on moderate-to-severe depression: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0016.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: We aim to assess the antidepressant effects of statin therapy among patients complicated with moderate to severe depression. Condition being studied: Depression is one of the major causes of disability worldwide, and major depressive disorders (MDD) contribute to a significant heavy disease burden, which is expected to be second by 2050, only to heart disease. Despite great improvement in therapy, the treatment efficacy remains low. Therefore, alternative therapies have been intensely investigated. A substantial body of researches have suggested that inflammation is one of the operative pathways between MDD and increased risk of somatic comorbidities, and some specific depressive symptoms. Depression occurs in most patients with cardiac and cerebrovascular disease due to the long-term effects, and depression increases the risk of cardiovascular disease in the population as a whole and in patients with coronary artery disease or stroke. Several observational studies have demonstrated reduced rates of depression among patients taking statins, which may be related to its anti-inflammatory effect. However, whether statin improves the depressive symptoms and its associated mechanism is still mixed. Furthermore, there is little evidence about statin treatment effect in those with moderate to severe depression. In addition, whether the effect of statin treatment on depressive symptom changes with time or is affected by baseline depression severity or percentage change of lipid levels has not been explored in previous studies.
5

Li, Tian, Shanshan Jin, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin, et al. Metformin may reduce the mortality and cardiac events in patients with cardio-cerebrovascular diseases, irrespective of concurrent diabetes: a meta-analysis of randomized controlled trails and cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0008.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії